D. E. Shaw & Co., Inc. - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CONMED CORP
ValueSharesWeighting
Q3 2021$6,417,000
+142.8%
4,135,000
+152.9%
0.01%
+200.0%
Q2 2021$2,643,000
-72.3%
1,635,000
-73.2%
0.00%
-77.8%
Q1 2021$9,550,000
+11.8%
6,100,0000.0%0.01%
+12.5%
Q4 2020$8,540,000
+52.2%
6,100,000
+22.0%
0.01%
+33.3%
Q3 2020$5,611,000
+7.4%
5,000,0000.0%0.01%0.0%
Q2 2020$5,226,0005,000,0000.01%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,840,000$3,958,0004.02%
ZAZOVE ASSOCIATES LLC 13,564,000$18,956,0002.33%
SHENKMAN CAPITAL MANAGEMENT INC 10,584,000$15,014,0001.57%
SSI INVESTMENT MANAGEMENT LLC 8,349,000$11,673,0000.83%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$12,528,0000.75%
MACKAY SHIELDS LLC 32,384,000$45,397,0000.31%
ADVENT CAPITAL MANAGEMENT /DE/ 8,379,000$11,734,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 5,271,000$7,387,0000.19%
Calamos Advisors LLC 23,007,000$32,262,0000.19%
WESTWOOD HOLDINGS GROUP INC 10,200,000$14,415,0000.17%
View complete list of CONMED CORP shareholders